• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical trials with blocked ricin immunotoxins.

作者信息

O'Toole J E, Esseltine D, Lynch T J, Lambert J M, Grossbard M L

机构信息

Hematology-Oncology Unit, Massachusetts General Hospital, Boston 02114, USA.

出版信息

Curr Top Microbiol Immunol. 1998;234:35-56. doi: 10.1007/978-3-642-72153-3_3.

DOI:10.1007/978-3-642-72153-3_3
PMID:9670611
Abstract
摘要

相似文献

1
Clinical trials with blocked ricin immunotoxins.
Curr Top Microbiol Immunol. 1998;234:35-56. doi: 10.1007/978-3-642-72153-3_3.
2
Chimeric antigen receptor T-cell immunotherapy tackles blood cancers.嵌合抗原受体T细胞免疫疗法可治疗血癌。
J Natl Cancer Inst. 2015 Apr 2;107(4). doi: 10.1093/jnci/djv112. Print 2015 Apr.
3
Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies.双特异性、T 细胞募集抗体在 B 细胞恶性肿瘤中的应用。
Front Immunol. 2020 May 7;11:762. doi: 10.3389/fimmu.2020.00762. eCollection 2020.
4
Biannual report of the Cochrane Haematological Malignancies Group.考克兰血液系统恶性肿瘤研究小组年度报告
J Natl Cancer Inst. 2004 Aug 4;96(15):E2. doi: 10.1093/jnci/djh242.
5
Monoclonal antibodies as carriers of toxins.作为毒素载体的单克隆抗体。
Prog Clin Biol Res. 1989;288:403-12.
6
In vitro treatment of bone marrow from patients with T-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma using the immunotoxin WT1-ricin A.
Haematol Blood Transfus. 1987;31:57-8. doi: 10.1007/978-3-642-72624-8_12.
7
Clinical Development of PD-1 Blockade in Hematologic Malignancies.血液系统恶性肿瘤中PD-1阻断的临床开发
Cancer J. 2018 Jan/Feb;24(1):31-35. doi: 10.1097/PPO.0000000000000297.
8
The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: pharmacokinetics and biodistribution of two divalent, ricin-based immunotoxins in xenografted athymic mice.作为免疫治疗靶点的慢性淋巴细胞白血病抗原（cCLLa）：两种基于蓖麻毒素的二价免疫毒素在异种移植裸鼠体内的药代动力学和生物分布
Leuk Lymphoma. 1997 May;25(5-6):509-20. doi: 10.3109/10428199709039039.
9
Treatment of leukemia patients with T101 ricin A chain immunotoxins.用T101蓖麻毒素A链免疫毒素治疗白血病患者。
Cancer Treat Res. 1988;37:483-91. doi: 10.1007/978-1-4613-1083-9_27.
10
Prospects for immunotoxin therapy of non-Hodgkin's lymphoma.非霍奇金淋巴瘤免疫毒素疗法的前景
Clin Immunol Immunopathol. 1995 Aug;76(2):107-14. doi: 10.1006/clin.1995.1103.

引用本文的文献

1
Antibody-Drug Conjugates for Multiple Myeloma: Just the Beginning, or the Beginning of the End?用于多发性骨髓瘤的抗体药物偶联物：只是开端，还是终结的开始？
Pharmaceuticals (Basel). 2023 Apr 14;16(4):590. doi: 10.3390/ph16040590.
2
Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins.含弗林裂解位点的蓖麻毒素 α-桑椹或 RNase T1 型免疫毒素增强对结直肠癌细胞的抗肿瘤疗效。
Toxins (Basel). 2019 Oct 12;11(10):593. doi: 10.3390/toxins11100593.
3
A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.
一种新型癌胚抗原（CEA）靶向三聚体免疫毒素在人结直肠癌细胞异种移植瘤中显示出显著增强的抗肿瘤活性。
Sci Rep. 2019 Aug 12;9(1):11680. doi: 10.1038/s41598-019-48285-z.
4
Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.免疫毒素由核糖体失活蛋白及其增强子构建：具有肿瘤特异性疗效的致命鸡尾酒。
Curr Pharm Des. 2014;20(42):6584-643. doi: 10.2174/1381612820666140826153913.
5
A calcium ion-dependent dimeric bean lectin with antiproliferative activity toward human breast cancer MCF-7 cells.一种钙离子依赖性二聚体豆科植物凝集素，对人乳腺癌 MCF-7 细胞具有抗增殖活性。
Protein J. 2013 Mar;32(3):208-15. doi: 10.1007/s10930-013-9477-2.
6
Immunotoxins for targeted cancer therapy.用于靶向癌症治疗的免疫毒素。
AAPS J. 2006 Aug 18;8(3):E532-51. doi: 10.1208/aapsj080363.
7
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.通过人T细胞克隆鉴定蓖麻毒素A链HLA II类限制性表位
Clin Exp Immunol. 2001 Sep;125(3):391-400. doi: 10.1046/j.1365-2249.2001.01525.x.